Outcome of transcatheter aortic valve replacement in Israeli Jews and Arabs

• DOI: 10.21037/jtd-23-1391
• Publication Date: 2024-01-30T09:41:51Z
• Authors: Hussein Sliman; Amnon Eitan; Avinoam Shiran; Barak Zafrir; Basheer Karkabai; Moshe Y. Flugelman; Naama Schwartz; Ronen Jaffe
• Keywords: Valve replacement

Background: Ethnic minorities may face disparities in access to health care and clinical outcomes. Transcatheter aortic valve replacement (TAVR) has an established role treatment of patients with severe symptomatic stenosis, however outcome these procedures among different demographics within the multi-ethnic Israeli society is unknown. We sought compare mortality following TAVR between Jewish Arab Israel. Methods: A prospective single-center registry northern Israel was analyzed. compared post-procedural survival who underwent TAVR, presenting estimated hazard ratio (HR) using Cox regression. Results: Of 923 subjects 2010–2021, 172 (19%) were 751 (81%) Jewish. The patient population younger (mean 77 vs. 81 years, P<0.001), had lower prevalence coronary artery disease (34%, 43%, P=0.02), hypertension (80% 88%, P<0.01) calculated procedural (EuroScore II: mean 4.6 4.9, higher percentage females (65% 53%, P=0.01), body mass index 30 28, P<0.001) creatinine clearance 67 59 mL/min, P<0.001). similar [7-day mortality: adjusted HR 1.51, 95% confidence interval (CI): 0.39–5.77, P=0.55; 30-day 1.79, CI: 0.62–5.18, P=0.29; 1-year 1.24, 0.72–2.12, P=0.43]. Conclusions: undergoing predicted than counterparts, however, characteristics did not translate into improved survival.